Join us as Wendy Selking, Consultant Pharmacist with InTouch Pharmaceuticals, discusses this new drug from Eisai and Biogen that clears the amyloid plaque build-up in the brain associated with Alzheimer’s disease. The Centers for Medicare and Medicaid Services will expand coverage of the new drug, broadening access for people with early forms of the disease and making it more accessible.